Zhou Yong-Ning, Xu Cai-Pu, Han Biao, Ji Rui
Center of Endoscopy, The First Hospital, Lanzhou University, Lanzhou, Gansu, P. R. China.
Ai Zheng. 2005 Oct;24(10):1220-4.
BACKGROUND & OBJECTIVE: Transcriptional silencing by CpG island methylation is now believed to be an important mechanism of carcinogenesis. E-cadherin can suppress tumor cell invasion and metastasis, and is considered as an invasion/metastasis suppressor gene. Inactivation of E-cadherin gene often occurs in poorly differentiated gastric carcinoma. This study was to investigate the CpG island methylation status of E-cadherin gene promoter in primary human gastric carcinomas and adjacent gastric tissues, and to explore the mechanism of gastric carcinogenesis.
The CpG island methylation status of E-cadherin gene promoter in 51 specimens of primary human gastric carcinoma, 37 specimens of adjacent gastric tissue, and 12 specimens of normal gastric mucosa was detected by methylation-specific polymerase chain reaction (MSP). The expression of E-cadherin was evaluated by immunohistochemistry.
The CpG island methylaion was not detected in normal gastric mucosa, but detected in 32 (62.7%) gastric carcinoma specimens and 4 (10.8%) adjacent gastric specimens. It occurred more frequently in poorly differentiated carcinomas than in well differentiated carcinomas [72.2% (26/36) vs. 33.3% (6/15), P<0.01], and it was presented at similar rates in stage T1/T2 carcinomas and stage T3/T4 carcinomas [55.6% (10/18) and 66.7% (22/33), P>0.05]. Down-regulation of E-cadherin expression was detected in 84.5% (27/32) tumor tissues with methylated CpG island and 26.3% (5/19) tumor tissues with unmethylated CpG island. No statistical correlation was found between CpG island methylaion and Helicobacter pylori infection.
The CpG island methylaion of E-cadherin gene promoter commonly exists in gastric carcinoma, particularly in poorly differentiated adenocarcinoma. E-cadherin promoter methylation may be involved in the early process of gastric carcinogenesis, but has no correlation to Helicobacter pylori infection.
目前认为,CpG岛甲基化介导的转录沉默是肿瘤发生的重要机制。E-钙黏蛋白可抑制肿瘤细胞的侵袭和转移,被视为一种侵袭/转移抑制基因。E-钙黏蛋白基因失活常见于低分化胃癌。本研究旨在探讨人原发性胃癌及癌旁胃组织中E-钙黏蛋白基因启动子区域CpG岛甲基化状态,以探索胃癌发生机制。
采用甲基化特异性聚合酶链反应(MSP)检测51例人原发性胃癌组织、37例癌旁胃组织及12例正常胃黏膜组织中E-钙黏蛋白基因启动子区域CpG岛甲基化状态。采用免疫组织化学法检测E-钙黏蛋白的表达。
正常胃黏膜中未检测到CpG岛甲基化,而在32例(62.7%)胃癌组织及4例(10.8%)癌旁胃组织中检测到CpG岛甲基化。低分化癌中CpG岛甲基化发生率高于高分化癌[72.2%(26/36)比33.3%(6/15),P<0.01],T1/T2期癌与T3/T4期癌中CpG岛甲基化发生率相近[55.6%(10/18)与66.7%(22/33),P>0.05]。在CpG岛甲基化的肿瘤组织中,84.5%(27/32)检测到E-钙黏蛋白表达下调;在CpG岛未甲基化的肿瘤组织中,26.3%(5/19)检测到E-钙黏蛋白表达下调。CpG岛甲基化与幽门螺杆菌感染之间无统计学相关性。
E-钙黏蛋白基因启动子区域CpG岛甲基化在胃癌中普遍存在,尤其在低分化腺癌中。E-钙黏蛋白启动子甲基化可能参与胃癌发生的早期过程,但与幽门螺杆菌感染无关。